FIELD: medicine. SUBSTANCE: method involves examining patient blood serum in passive hemagglutination reaction with benign, anaplastic and glioblastoma erythrocytic diagnostics with polyantigenic preparations of tissues of the corresponding glial neoplasms. Positive results being obtained with benign and anaplastic diagnosticum or with benign one only, benign glial tumors are to be diagnosed. Positive reactions being observed with all diagnostics, glial tumors are to be diagnosed as malignant tumors. Positive reactions being observed with anaplastic and glioblastoma diagnostics, malignant glioblastoma tumors are to be diagnosed. EFFECT: enhanced accuracy of diagnosis; simplified and accelerated method. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSTICS OF IMPAIRED HEARING | 0 |
|
SU1332230A1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF BENIGN, PRIMARY AND SECONDARY MALIGNANT BRAIN TUMORS | 2016 |
|
RU2628816C1 |
METHOD FOR PREDICTING RELAPSES AND METASTASES OF PULMONARY CANCER | 2003 |
|
RU2243564C1 |
METHOD OF PREDICTING SURVIVAL POTENTIAL OF PATIENTS WITH MALIGNANT GLIOMAS | 2010 |
|
RU2439577C2 |
METHOD FOR DIAGNOSING VOLUMETRIC FORMATIONS OF THE BRAIN | 2021 |
|
RU2754836C1 |
METHOD OF DIAGNOSIS OF HEAD BRAIN NEW FORMATIONS | 0 |
|
SU664505A1 |
METHOD OF DIAGNOSING BRAIN TUMOURS | 2013 |
|
RU2562573C2 |
METHOD OF DIAGNOSTICS OF MALIGNANT NEOPLASMS OF THE BRAIN | 2017 |
|
RU2673659C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF HIGH GRADE GLIOMAS | 2022 |
|
RU2786003C1 |
METHOD FOR INDICATING THE EFFECTIVENESS OF COMBINED ADAPTIVE STEREOTACTIC RADIOTHERAPY WITH BEVACIZUMAB IN MEN WITH MALIGNANT BRAIN GLIOMAS | 2023 |
|
RU2801419C1 |
Authors
Dates
2000-08-20—Published
1999-11-30—Filed